COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, Jan. 13, 2022 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
8,793 new cases, bringing the total number of people infected to 775,720*;
45 new deaths, for a total of 12,125 deaths;
2,994 hospitalizations, for an increase of 117 compared to the previous day;
443 new entries,
326 new discharges;
272 people in intensive care, for an increase of 9 compared to the previous day;
44 new entries,
35 new discharges;
43,320 samples conducted on January 11.
*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.
Vaccination
116,101 doses administered are added, that is 111,395 doses in the last 24 hours and 4,711 doses before January 12, for a total of 16,080,391 doses administered in Québec. Outside Québec, a total of 257,300 doses were administered, for a cumulative total of 16,337,691 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...